Microbial genomics.
Saved in:
VerfasserIn: | |
---|---|
TeilnehmendeR: | |
Place / Publishing House: | [London] : : Society for General Microbiology,, 2015- London : : Microbiology Society |
Publication history: | Began with Volume 1, issue 1 (July 2015). |
Language: | English |
Physical Description: | 1 online resource |
Notes: | Refereed/Peer-reviewed |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
993575856404498 |
---|---|
lccn |
2016229665 |
ctrlnum |
(OCoLC)915087449 (CKB)3780000000055208 (CONSER)--2016229665 (DE-599)ZDB2835258-0 (NjHacI)993780000000055208 (EXLCZ)993780000000055208 |
collection |
bib_alma |
record_format |
marc |
spelling |
Society for General Microbiology, author, issuing body. MICROB GENOM Microbial genomics Microbial genomics. MGen July 2015-Aug. 2015: [London] : Society for General Microbiology, 2015- Sept. 2015- : London : Microbiology Society 1 online resource Monthly text txt rdacontent computer c rdamedia online resource cr rdacarrier Began with Volume 1, issue 1 (July 2015). Description based on: Volume 1, issue 1 (July 2015); title from journal home page (publisher's website, viewed May 16, 2016). Latest issue consulted: Volume 2, issue 4 (April 2016) (viewed May 16, 2016). Refereed/Peer-reviewed Unrestricted online access star Efficacy and direct costs of chronic hepatitis C treatment with first generation NS3/4A protease inhibitors in a real life population -- Efficacy of HCV treatment in Poland at the turn of the interferon era - the EpiTer study -- Prevalence of HCV genotypes in Poland - the EpiTer study -- Simple non-invasive markers for early diagnosis and determination of the severity of liver diseases -- The influence of anti-HBc status on the sustained virological response rate in HCV-infected patients treated with pegylated interferon alfa 2 and ribavirin -- The occurrence of autoantibodies in patients with chronic HCV infection, including patients dialyzed and after kidney transplantation. Microbial genomics Periodicals. Genomics. Microbial genomics. fast (OCoLC)fst01019505 Genome, Microbial. Periodicals. lcgft Periodical. Periodicals. fast (OCoLC)fst01411641 Fulltext. Internet Resources. Periodicals. Society for General Microbiology, issuing body. Microbiology Society, issuing body. |
language |
English |
format |
Journal |
author2 |
Society for General Microbiology, Microbiology Society, |
author_facet |
Society for General Microbiology, Microbiology Society, Society for General Microbiology, |
author2_role |
TeilnehmendeR TeilnehmendeR |
author_corporate |
Society for General Microbiology, |
author_corporate_role |
VerfasserIn |
author_sort |
Society for General Microbiology, |
title |
Microbial genomics. |
spellingShingle |
Microbial genomics. Efficacy and direct costs of chronic hepatitis C treatment with first generation NS3/4A protease inhibitors in a real life population -- Efficacy of HCV treatment in Poland at the turn of the interferon era - the EpiTer study -- Prevalence of HCV genotypes in Poland - the EpiTer study -- Simple non-invasive markers for early diagnosis and determination of the severity of liver diseases -- The influence of anti-HBc status on the sustained virological response rate in HCV-infected patients treated with pegylated interferon alfa 2 and ribavirin -- The occurrence of autoantibodies in patients with chronic HCV infection, including patients dialyzed and after kidney transplantation. |
title_short |
MICROB GENOM |
title_full |
Microbial genomics. |
title_fullStr |
Microbial genomics. |
title_full_unstemmed |
Microbial genomics. |
title_auth |
Microbial genomics. |
title_new |
Microbial genomics. |
title_sort |
microbial genomics. |
publisher |
Society for General Microbiology, Microbiology Society |
publishDate |
2015 |
physical |
1 online resource |
dateSpan |
Began with Volume 1, issue 1 (July 2015). |
contents |
Efficacy and direct costs of chronic hepatitis C treatment with first generation NS3/4A protease inhibitors in a real life population -- Efficacy of HCV treatment in Poland at the turn of the interferon era - the EpiTer study -- Prevalence of HCV genotypes in Poland - the EpiTer study -- Simple non-invasive markers for early diagnosis and determination of the severity of liver diseases -- The influence of anti-HBc status on the sustained virological response rate in HCV-infected patients treated with pegylated interferon alfa 2 and ribavirin -- The occurrence of autoantibodies in patients with chronic HCV infection, including patients dialyzed and after kidney transplantation. |
issn |
2057-5858 |
callnumber-first |
Q - Science |
callnumber-subject |
QH - Natural History and Biology |
callnumber-label |
QH434 |
callnumber-sort |
QH 3434 S635 42015 |
genre |
Periodicals. lcgft Periodical. Periodicals. fast (OCoLC)fst01411641 Fulltext. Internet Resources. Periodicals. |
genre_facet |
Periodicals. Periodical. Fulltext. Internet Resources. |
illustrated |
Illustrated |
dewey-hundreds |
500 - Science |
dewey-tens |
570 - Life sciences; biology |
dewey-ones |
579 - Microorganisms, fungi & algae |
dewey-full |
579.3135 |
dewey-sort |
3579.3135 |
dewey-raw |
579.3135 |
dewey-search |
579.3135 |
oclc_num |
915087449 |
work_keys_str_mv |
AT societyforgeneralmicrobiology microbialgenomics AT microbiologysociety microbialgenomics AT societyforgeneralmicrobiology mgen AT microbiologysociety mgen |
status_str |
n |
ids_txt_mv |
(OCoLC)915087449 (CKB)3780000000055208 (CONSER)--2016229665 (DE-599)ZDB2835258-0 (NjHacI)993780000000055208 (EXLCZ)993780000000055208 |
carrierType_str_mv |
cr |
is_hierarchy_title |
Microbial genomics. |
author2_original_writing_str_mv |
noLinkedField noLinkedField |
_version_ |
1796652709126864896 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nas-a2200517-i-4500</leader><controlfield tag="001">993575856404498</controlfield><controlfield tag="005">20211118213022.0</controlfield><controlfield tag="006">m-----o--d--------</controlfield><controlfield tag="007">cr-|||||||||||</controlfield><controlfield tag="008">150729c20159999enkmr-p-o-----0----0eng-c</controlfield><datafield tag="010" ind1=" " ind2=" "><subfield code="a"> 2016229665</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">2835258-0</subfield><subfield code="2">DE-600</subfield></datafield><datafield tag="022" ind1=" " ind2=" "><subfield code="a">2057-5858</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)915087449</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)3780000000055208</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CONSER)--2016229665</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)ZDB2835258-0</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(NjHacI)993780000000055208</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)993780000000055208</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">NjHacI</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="c">NjHacI</subfield></datafield><datafield tag="042" ind1=" " ind2=" "><subfield code="a">pcc</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">QH434</subfield><subfield code="b">.S635 2015</subfield></datafield><datafield tag="060" ind1="0" ind2="0"><subfield code="a">W1</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">579.3135</subfield><subfield code="2">23</subfield></datafield><datafield tag="110" ind1="2" ind2=" "><subfield code="a">Society for General Microbiology,</subfield><subfield code="e">author,</subfield><subfield code="e">issuing body.</subfield></datafield><datafield tag="210" ind1=" " ind2=" "><subfield code="a">MICROB GENOM</subfield></datafield><datafield tag="222" ind1=" " ind2="0"><subfield code="a">Microbial genomics</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Microbial genomics.</subfield></datafield><datafield tag="246" ind1="1" ind2=" "><subfield code="a">MGen</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="3">July 2015-Aug. 2015:</subfield><subfield code="a">[London] :</subfield><subfield code="b">Society for General Microbiology,</subfield><subfield code="c">2015-</subfield></datafield><datafield tag="264" ind1="3" ind2="1"><subfield code="3">Sept. 2015- :</subfield><subfield code="a">London :</subfield><subfield code="b">Microbiology Society</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource</subfield></datafield><datafield tag="310" ind1=" " ind2=" "><subfield code="a">Monthly</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="362" ind1="1" ind2=" "><subfield code="a">Began with Volume 1, issue 1 (July 2015).</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on: Volume 1, issue 1 (July 2015); title from journal home page (publisher's website, viewed May 16, 2016).</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Latest issue consulted: Volume 2, issue 4 (April 2016) (viewed May 16, 2016).</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Refereed/Peer-reviewed</subfield></datafield><datafield tag="506" ind1="0" ind2=" "><subfield code="f">Unrestricted online access</subfield><subfield code="2">star</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">Efficacy and direct costs of chronic hepatitis C treatment with first generation NS3/4A protease inhibitors in a real life population -- Efficacy of HCV treatment in Poland at the turn of the interferon era - the EpiTer study -- Prevalence of HCV genotypes in Poland - the EpiTer study -- Simple non-invasive markers for early diagnosis and determination of the severity of liver diseases -- The influence of anti-HBc status on the sustained virological response rate in HCV-infected patients treated with pegylated interferon alfa 2 and ribavirin -- The occurrence of autoantibodies in patients with chronic HCV infection, including patients dialyzed and after kidney transplantation.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Microbial genomics</subfield><subfield code="v">Periodicals.</subfield></datafield><datafield tag="650" ind1="1" ind2="2"><subfield code="a">Genomics.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Microbial genomics.</subfield><subfield code="2">fast</subfield><subfield code="0">(OCoLC)fst01019505</subfield></datafield><datafield tag="650" ind1="2" ind2="2"><subfield code="a">Genome, Microbial.</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="a">Periodicals.</subfield><subfield code="2">lcgft</subfield></datafield><datafield tag="655" ind1=" " ind2="2"><subfield code="a">Periodical.</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="a">Periodicals.</subfield><subfield code="2">fast</subfield><subfield code="0">(OCoLC)fst01411641</subfield></datafield><datafield tag="655" ind1=" " ind2="4"><subfield code="a">Fulltext.</subfield></datafield><datafield tag="655" ind1=" " ind2="4"><subfield code="a">Internet Resources.</subfield></datafield><datafield tag="655" ind1=" " ind2="4"><subfield code="a">Periodicals.</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">Society for General Microbiology,</subfield><subfield code="e">issuing body.</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">Microbiology Society,</subfield><subfield code="e">issuing body.</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">JOURNAL</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2024-02-25 02:48:19 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2015-07-04 21:11:25 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAJ Directory of Open Access Journals</subfield><subfield code="P">DOAJ Directory of Open Access Journals</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5342336190004498&Force_direct=true</subfield><subfield code="Z">5342336190004498</subfield><subfield code="m"> Available from 2016.</subfield><subfield code="b">Available</subfield><subfield code="8">5342336190004498</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="Z">5342336190004498</subfield><subfield code="A">2016</subfield></datafield></record></collection> |